| mRNA |
dabrafenib |
CTRPv2 |
pan-cancer |
AAC |
0.32 |
5e-09 |
| mRNA |
PLX4720 |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
2e-08 |
| mRNA |
dabrafenib |
GDSC1000 |
pan-cancer |
AAC |
0.18 |
3e-08 |
| mRNA |
SR-II-138A |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
2e-06 |
| mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
3e-06 |
| mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
5e-06 |
| mRNA |
paclitaxel |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
5e-06 |
| mRNA |
KX2-391 |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
1e-05 |
| mRNA |
PLX4720 |
GDSC1000 |
pan-cancer |
AAC |
0.15 |
1e-05 |
| mRNA |
vincristine |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
1e-05 |